Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Arm-hand BOOST therapy to improve recovery after stroke

Official title: Aha BOOST Arm-hand BOOST Therapy to Enhance Recovery After Stroke: Clinical, Health Economic and Process Evaluation

Run by KU Leuven · NCT06517251 · Data updated 2026-11-12

This study is testing if a new arm-hand therapy can help people recovering from a stroke get better faster compared to a standard treatment.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorKU Leuven
Academic / other
Locations2 sites (Edegem, Antwerpen and 1 other locations)
StatusRecruiting
StartedJune 17, 2024
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedMarch 19, 2026
Trial IDNCT06517251 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have experienced a first-ever unilateral stroke within the last five months and have specific motor impairments in the upper limb.

Probably not a fit

Patients with severe communication or cognitive deficits may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness and cost-effectiveness of arm-hand BOOST therapy in enhancing recovery for patients in the sub-acute phase after a stroke. Eighty patients will be recruited from two inpatient rehabilitation wards in Belgium and randomly assigned to receive either the arm-hand BOOST therapy or a control intervention, L-BOOST, alongside their usual care. The arm-hand BOOST program includes group exercises focused on neurophysiology, reaching and grasping sequences, de-weighting of the arm, and hand orientation, supplemented by technology-supported therapy. Data will be collected through standardized forms and digital platforms to assess clinical outcomes and process evaluations.

Why it matters

Potential benefit: If successful, this therapy could significantly improve upper limb recovery and overall rehabilitation outcomes for stroke patients.

How similar studies have gone: Other studies have shown promise in similar therapeutic approaches, suggesting potential for success in this intervention.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Maximally 5 months after a first-ever unilateral, supra-tentorial stroke
* Minimally 18 years old
* A residual inpatient stay of minimally 4 weeks
* The ability to sit independently
* Motor impairment in the upper limb, as defined, based on the JSU diagram, as a score of 8-17 on stage 2 (synergies) of the Fugl-Meyer assessment upper extremity (FMA-UE) or a score of \<8 on stage 2 of the FMA-UE, combined with a score of \>6 on stage 5 (hand) of the FMA-UE.

Exclusion Criteria:

* Severe communication deficits as defined as a score of \<24 out of 32 on the 'visual sentence comprehension' subscale of the Comprehensive Aphasia Test.
* Severe cognitive deficits as defined as a score of \<18 out of 30 on the Montreal Cognitive Assessment.

Where it's running

  • Revalidatieziekenhuis RevArte
    Edegem, Antwerpen, Belgium
    Recruiting
  • Revalidatiecentrum K7 UZ Gent
    Ghent, Oost-Vlaanderen, Belgium
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.